| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Chua-On, D Proungvitaya, T Techasen, A Limpaiboon, T Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sungkhamanon, S Proungvitaya, S |
2016 | ||||
| 2. | Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells | Dokduang, H Yongvanit, P Namwat, N Pairojkul, C Sangkhamanon, S Yageta, MS Murakami, Y Loilome, W |
2016 | ||||
| 3. | Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment. | Supak Yothaisong Hasaya Dokduang Naohiko Anzai Keitaro Hayashi Nisana Namwat Puangrat Yongvanit Sakkarn Sangkhamanon Promsuk Jutabha Hitoshi Endou Watcharin Loilome |
2017 | ||||
| 4. | MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma | Kulyada Somsap Nittaya Chamadol Attapol Titapun Chawalit Pairojkul Sakkarn Sangkhamanon |
2017 | ||||
| 5. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. | Sureerat Padthaisong Malinee Thanee Anchalee Techasen Nisana Namwat Puangrat Yongvanit Aekkaphod Liwatthakun Khittisak Hankla Sakkarn Sangkhamanon Watcharin Loilome |
2017 | ||||
| 6. | Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma | Sangkhamanon, S Jongpairat, P Sookprasert, A Wirasorn, K Titapun, A Pugkhem, A Ungareevittaya, P Chindaprasirt, J |
2017 | ||||
| 7. | Targeting hexokinase II as a possible therapy for cholangiocarcinoma | Thamrongwaranggoon, U Seubwai, W Phoomak, C Sangkhamanon, S Cha'on, U Boonmars, T Wongkham, S |
2017 | ||||
| 8. | Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis | Nattaporn Phanthaphol Anchalee Techasen Watcharin Loilome Suyanee Thongchot Raynoo Thanan Sakkarn Sungkhamanon Narong Khuntikeo Puangrat Yongvanit Nisana Namwat |
2017 | ||||
| 9. | Biopsy Global Grade Group vs. Highest Grade Group vs. Largest Volume Cancer Grade Group: Concordance of Biopsy 'Case Level' and Radical Prostatectomy Grade Groups | Kiril Trpkov Sakkarn Sangkhamanon Asli Yilmaz Shaun Medlicott Panche Zdravkovski Tarek Bismar Melissa A. Shea-Budgell |
2018 | ||||
| 10. | Bladder Malakoplakia in Systemic Sclerosis Patient: A Case Report and Review Literature. | Sirithanaphol, W Sangkhamanon, S Netwijitpan, S Foocharoen, C |
2018 | ||||
| 11. | Concordance of "Case Level" Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy. | Kiril Trpkov Sakkarn Sangkhamanon Asli Yilmaz Shaun A. C. Medlicott Bryan Donnelly Geoffrey Gotto Melissa Shea-Budgell |
2018 | ||||
| 12. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth | Padthaisong, S Dokduang, H Yothaisong, S Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Titapun, A Sangkhamanon, S Loilome, W |
2018 | ||||
| 13. | Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 | ||||
| 14. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 | ||||
| 15. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 | ||||
| 16. | Gleason Grading: Clear and Straightforward Rules Facilitate Judgment. | Trpkov, K Yilmaz, A Sangkhamanon, S Medlicott, S Donnelly, B Gotto, G Shea-Budgell, M |
2019 | ||||
| 17. | Infantile cardiac hemangioma causing right ventricular inflow obstruction. | Karunasumetta, C Wongbhuddha, C Sangkhamanon, S Mokarat, B |
2019 | ||||
| 18. | Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma | Doungdean Tummanatsakun Tanakorn Proungvitaya Sittiruk Roytrakul Temduang Limpaiboon Sopit Wongkham Chaisiri Wongkham Atit Silsirivanit Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 | ||||
| 19. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma. | Surangkana Sanmai Tanakorn Proungvitaya Temduang Limpaiboon Daraporn Chua-On Wunchana Seubwai Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 | ||||
| 20. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Sungkhamanon, S Saya, H Loilome, W |
2020 | Count | 0 | 14 | 15 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total | ||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma. | Chua-On, D Proungvitaya, T Techasen, A Limpaiboon, T Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sungkhamanon, S Proungvitaya, S |
2016 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (37), pp. 13659-13667 |
|
| 2. | Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells. | Dokduang, H Yongvanit, P Namwat, N Pairojkul, C Sangkhamanon, S Yageta, MS Murakami, Y Loilome, W |
2016 |
Oncology reports 4 (35), pp. 2065-72 |
|
| 3. | Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment. | Yothaisong, S Dokduang, H Anzai, N Hayashi, K Namwat, N Yongvanit, P Sangkhamanon, S Jutabha, P Endou, H Loilome, W |
2017 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 3 (39), pp. 1010428317694545 |
|
| 4. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. | Padthaisong, S Thanee, M Techasen, A Namwat, N Yongvanit, P Liwatthakun, A Hankla, K Sangkhamanon, S Loilome, W |
2017 |
Anticancer research 7 (37), pp. 3591-3597 |
|
| 5. | Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma | Sangkhamanon, S Jongpairat, P Sookprasert, A Wirasorn, K Titapun, A Pugkhem, A Ungareevittaya, P Chindaprasirt, J |
2017 |
Asian Pacific journal of cancer prevention : APJCP 6 (18), pp. 1671-1674 |
|
| 6. | Targeting hexokinase II as a possible therapy for cholangiocarcinoma. | Thamrongwaranggoon, U Seubwai, W Phoomak, C Sangkhamanon, S Cha'on, U Boonmars, T Wongkham, S |
2017 |
Biochemical and biophysical research communications 2 (484), pp. 409-415 |
|
| 7. | Bladder Malakoplakia in Systemic Sclerosis Patient: A Case Report and Review Literature. | Sirithanaphol, W Sangkhamanon, S Netwijitpan, S Foocharoen, C |
2018 |
Journal of endourology case reports 1 (4), pp. 91-93 |
|
| 8. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 |
Oncology letters 1 (15), pp. 347-353 |
|
| 9. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. | Padthaisong, S Dokduang, H Yothaisong, S Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Titapun, A Sangkhamanon, S Loilome, W |
2018 |
Oncology letters 2 (16), pp. 1627-1633 |
|
| 10. | Concordance of "Case Level" Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy. | Trpkov, K Sangkhamanon, S Yilmaz, A Medlicott, SAC Donnelly, B Gotto, G Shea-Budgell, M |
2018 |
The American journal of surgical pathology 11 (42), pp. 1522-1529 |
|
| 11. | Gleason Grading: Clear and Straightforward Rules Facilitate Judgment. | Trpkov, K Yilmaz, A Sangkhamanon, S Medlicott, S Donnelly, B Gotto, G Shea-Budgell, M |
2019 |
The American journal of surgical pathology 2 (43), pp. 291-292 |
|
| 12. | Infantile cardiac hemangioma causing right ventricular inflow obstruction. | Karunasumetta, C Wongbhuddha, C Sangkhamanon, S Mokarat, B |
2019 |
Asian cardiovascular & thoracic annals (), pp. 218492319836899 |
|
| 13. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma. | Sanmai, S Proungvitaya, T Limpaiboon, T Chua-On, D Seubwai, W Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sangkhamanon, S Proungvitaya, S |
2019 |
Oncology letters 6 (17), pp. 5275-5282 |
|
| 14. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Sungkhamanon, S Saya, H Loilome, W |
2020 |
Journal of translational medicine 1 (18), pp. 64 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total | ||||||
| 1. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Daraporn Chua-on Tanakorn Proungvitaya Anchalee Techasen Temduang Limpaiboon Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sungkhamanon Siriporn Proungvitaya |
2016 |
TUMOR BIOLOGY 10.0 (37.0), pp. 13659.0-13667.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 2. | Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells | Hasaya Dokduang Puangrat Yongvanit Nisana Namwat Chawalit Pairojkul Sakkarn Sangkhamanon Mika Sakurai Yageta Yoshinori Murakami Watcharin Loilome |
2016 |
ONCOLOGY REPORTS 4.0 (35.0), pp. 2065.0-2072.0 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 3. | Inhibition of L-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment | Supak Yothaisong Hasaya Dokduang Naohiko Anzai Keitaro Hayashi Nisana Namwat Puangrat Yongvanit Sakkarn Sangkhamanon Promsuk Jutabha Hitoshi Endou Watcharin Loilome |
2017 |
TUMOR BIOLOGY 3.0 (39.0), pp. |
19 | 0 | 0 | 0 | 0 | 0 | 19 | |
| 4. | MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma | Kulyada Somsap Nittaya Chamadol Attapol Titapun Chawalit Pairojkul Sakkarn Sangkhamanon |
2017 |
BJR CASE REPORTS 1.0 (3.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process | Sureerat Padthaisong Malinee Thanee Anchalee Techasen Nisana Namwat Puangrat Yongvanit Aekkaphod Liwatthakun Khittisak Hankla Sakkarn Sangkhamanon Watcharin Loilome |
2017 |
ANTICANCER RESEARCH 7.0 (37.0), pp. 3591.0-3597.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 6. | Targeting hexokinase II as a possible therapy for cholangiocarcinoma | Ubonrat Thamrongwaranggoon Wunchana Seubwai Chatchai Phoomak Sakkarn Sangkhamanon Ubon Cha'on Thidarat Boonmars Sopit Wongkham |
2017 |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2.0 (484.0), pp. 409.0-415.0 |
15 | 0 | 0 | 0 | 0 | 0 | 15 | |
| 7. | Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis | Nattaporn Phanthaphol Anchalee Techasen Watcharin Loilome Suyanee Thongchot Raynoo Thanan Sakkarn Sungkhamanon Narong Khuntikeo Puangrat Yongvanit Nisana Namwat |
2017 |
ONCOLOGY LETTERS 5.0 (14.0), pp. 5973.0-5979.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 8. | Biopsy Global Grade Group vs. Highest Grade Group vs. Largest Volume Cancer Grade Group: Concordance of Biopsy 'Case Level' and Radical Prostatectomy Grade Groups | Kiril Trpkov Sakkarn Sangkhamanon Asli Yilmaz Shaun Medlicott Panche Zdravkovski Tarek Bismar Melissa A. Shea-Budgell |
2018 |
MODERN PATHOLOGY (31.0), pp. 394.0-394.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 9. | Concordance of Case Level Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy | Kiril Trpkov Sakkarn Sangkhamanon Asli Yilmaz Shaun A. C. Medlicott Bryan Donnelly Geoffrey Gotto Melissa Shea-Budgell |
2018 |
AMERICAN JOURNAL OF SURGICAL PATHOLOGY 11.0 (42.0), pp. 1522.0-1529.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 10. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapol Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 |
ONCOLOGY LETTERS 2.0 (16.0), pp. 1627.0-1633.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 11. | Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 |
CANCER SCIENCE (109.0), pp. 745.0-745.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 12. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 |
ONCOLOGY LETTERS 1.0 (15.0), pp. 347.0-353.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 13. | Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma | Doungdean Tummanatsakun Tanakorn Proungvitaya Sittiruk Roytrakul Temduang Limpaiboon Sopit Wongkham Chaisiri Wongkham Atit Silsirivanit Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 |
BIOMOLECULES 9.0 (9.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 14. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Surangkana Sanmai Tanakorn Proungvitaya Temduang Limpaiboon Daraporn Chua-On Wunchana Seubwai Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 |
ONCOLOGY LETTERS 6.0 (17.0), pp. 5275.0-5282.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 15. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Sureerat Padthaisong Malinee Thanee Nisana Namwat Jutarop Phetcharaburanin Poramate Klanrit Narong Khuntikeo Attapol Titapun Sakkarn Sungkhamanon Hideyuki Saya Watcharin Loilome |
2020 |
JOURNAL OF TRANSLATIONAL MEDICINE 1.0 (18.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|